Mk-1454
Drug Oncology
General payments
$7,465
Research payments
$3,591,561
Through program year 2020, $7,465 in general payments and $3,591,561 in research payments were reported against Mk-1454 (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $7,045 | 16 |
| 2020 | Research | $1,703,144 | 629 |
| 2019 | General | $420 | 2 |
| 2019 | Research | $1,888,417 | 159 |
Breakdown
Each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2020 where a state was reported.
Records
18 general · 788 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.